IMPAACT at R4P 2021
The IMPAACT Network presented data from IMPAACT P1112 and IMPAACT 2009 at the 4th HIV Research for Prevention (HIVR4P) Conference, held virtually from 27-28 January and 3-4 February.
Safety and PK of potent anti-HIV monoclonal AB VRC07-523LS in HIV-exposed infants
C. Cunningham *, E. Capparelli, E. McFarland, P. Muresan, C. Perlowski, E. Smith, R. Hazra, L. Purdue, P. Harding, A. McDermott, J. Mascola, B. Graham
Wednesday, 27 January
Directly Observed Therapy (DOT) can be Implemented Successfully in Research Settings to Evaluate PrEP PK among Pregnant and Postpartum Adolescents and Young Women in Africa
*E. Brown, L. Stranix-Chibanda, B. Johnston, S. Huang, D. Kacanek, L. Mungate, A. Sango, S. Mambiya, W. Longwe Mwenda, V. Korutaro, S. Nanyunja, P. Kibalama Ssemambo, A. Ssekasi Miwanda, H. Kowo, S. Nelwamondo, H. Spiegel, P. Anderson, B. Chi, K. Lypen